Loading…

Loading grant details…

Completed NON-SBIR/STTR RPGS NIH (US)

Sox Proteins Modulate Genomic Specificity of B-catenin Regulated Transcription in the Developing Gut

$5.57M USD

Funder NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
Recipient Organization Cincinnati Childrens Hosp Med Ctr
Country United States
Start Date Jan 15, 2021
End Date Dec 31, 2024
Duration 1,446 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10540791
Grant Description

PROJECT SUMMARY/ABSTRACT This proposal will test the hypothesis that SOX transcription factors (TFs) modulate the genomic specificity of Wnt/Beta-catenin (BCAT) mediated transcription in early gut development and determine the underlying molecular mechanisms. Wnt signaling regulates gene expression in digestive system

development, homeostasis and disease, where it is an important therapeutic target. While the core Wnt transcriptional machinery is well studied, how cell-specific target genes are selected remains one of the most important unresolved issues in the field. Current dogma is that canonical Wnt stabilizes cytoplasmic BCAT, which

translocates to the nucleus and interacts with one of four TCF/LEF HMG-box TFs to stimulate transcription. However, all TCFs bind to nearly identical consensus sites indicating they alone cannot account for the diversity of transcriptional responses. Using the complementary advantages of Xenopus embryos and differentiating

human pluripotent stem cells (hPSC), we have accumulated compelling evidence that SOX HMG-box TFs modulate the genomic specificity of Wnt/BCAT-mediated transcription during early gut development. Our preliminary ChIP-seq data and functional analyses suggests that different SOX TFs can recruit BCAT to distinct

enhancers in a tissue specific manner. On some enhancers SOX and BCAT synergistically activate transcription independent of TCFs. Other enhancers appear to be co-occupied by SOX, BCAT and TCFs, suggesting tertiary complexes where SOX and TCF might cooperate or compete to bind DNA and BCAT to activate or represses

transcription. These data suggest novel regulatory mechanisms and indicate that SOXs may be wide-spread unappreciated factors regulating Wnt responses. We propose to test this hypothesis with the following aims: Aim 1: Test the hypothesis that SOXs regulate the genomic recruitment of BCAT to lineage specific enhancers.

Aim 2: Determine how Sox17 and Bcat coregulate Wnt-responsive enhancers to control spatially restricted transcription in the embryo. Aim 3: Determine the biochemical mechanisms by which SOX-BCAT-TCF complexes interact on DNA. These studies will reveal the SOX-BCAT regulated GRN of gut development and provide a new paradigm

for how cell-specific Wnt-mediated transcription is regulated in development and disease.

All Grantees

Cincinnati Childrens Hosp Med Ctr

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant